Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Brain Tumor Pathology
Published in: Brain Tumor Pathology 2/2024

01-04-2024 | Brain Tumor | Preface

Preface for Brain Tumor Pathology vol.41 issue 2

(Special issue for the 41st Annual Meeting of the Japan Society of Brain Tumor Pathology)

Author: Motoo Nagane

Published in: Brain Tumor Pathology | Issue 2/2024

Login to get access

Excerpt

It is my great pleasure and honor to have held the 41st Annual Meeting of the Japan Society of Brain Tumor Pathology on May 26th and 27th, 2023, at the Station Conference Tokyo. It was also a significant event for our institution, the Department of Neurosurgery and Pathology, Kyorin University Faculty of Medicine. …
Metadata
Title
Preface for Brain Tumor Pathology vol.41 issue 2
(Special issue for the 41st Annual Meeting of the Japan Society of Brain Tumor Pathology)
Author
Motoo Nagane
Publication date
01-04-2024
Publisher
Springer Nature Singapore
Published in
Brain Tumor Pathology / Issue 2/2024
Print ISSN: 1433-7398
Electronic ISSN: 1861-387X
DOI
https://doi.org/10.1007/s10014-024-00479-8

Other articles of this Issue 2/2024

Brain Tumor Pathology 2/2024 Go to the issue

Letter to the Editor

Intratumoral heterogeneity of CDKN2A deletions in IDH-mutant astrocytoma

Correction

Correction: Beyond the WHO 2021 classification of the tumors of the central nervous system: transitioning from the 5th edition to the next

Case Report

Rise of oligodendroglioma hypermutator phenotype from a subclone harboring TP53 mutation after TMZ treatment

Original Article

Clinical and radiological features of intracranial ancient schwannomas: a single-institution, retrospective analysis

Review Article

Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy

Rapid Short communication

Recent advances in liquid biopsy of central nervous system lymphomas: case presentations and review of the literature